Xiang Xu (X Xu)
Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 26
Publications (10 Years): 26
Third Military Medical University Daping Hospital and Research Institute of Surgery
Third Military Medical University Daping Hospital and Research Institute of Surgery (PHD)
Affiliation History
Third Military Medical University Daping Hospital and Research Institute of Surgery
Jul 31 2006
China
Associate director :: First Department
Education History
Third Military Medical University Daping Hospital and Research Institute of Surgery
Sep 01 2003
- Jul 31 2006
China
PHD :: First Department
Publications
- Zhuo Chen, Xuewei Xia, Mengwei Yao, Yi Yang, Xiang Ao, Zhaoqi Zhang, Li Guo, Xiang Xu
- Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan XiaXELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
- Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan XiaXELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
- Zhuo Chen, Xuewei Xia, Mengwei Yao, Yi Yang, Xiang Ao, Zhaoqi Zhang, Li Guo, Xiang Xu
- Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan XiaXELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
- Zhuo Chen, Xuewei Xia, Mengwei Yao, Yi Yang, Xiang Ao, Zhaoqi Zhang, Li Guo, Xiang Xu
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu, Ping Chen
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Shi-Dan Li, Wei Xing, Shao-Chuan Wang, You-Bin Li, Hao Jiang, Han-Xuan Zheng, Xiao-Ming Li, Jing Yang, De-Bin Guo, Xiao-Yu Xie, Ren-Qing Jiang, Chao Fan, Lei Li, Xiang Xu, Jun Fei
- Meng Kou, Li Huang, Jinjuan Yang, Zhixin Chiang, Shaoxiang Chen, Jie Liu, Liyan Guo, Xiaoxian Zhang, Xiaoya Zhou, Xiang Xu, Xiaomei Yan, Yan Wang, Jinqiu Zhang, Aimin Xu, Hung-Fat Tse, Qizhou Lian
- Mengwei Yao, Zhuo Chen, Xiao He, Jiaoyue Long, Xuewei Xia, Zhan Li, Yu Yang, Luoquan Ao, Wei Xing, Qizhou Lian, Hua-Ping Liang, Xiang Xu
- Weijun Wan, Xiang Ao, Quan Chen, Yang Yu, Luoquan Ao, Wei Xing, Wei Guo, Xiaofeng Wu, Chengxiu Pu, Xueting Hu, Zhan Li, Mengwei Yao, Donglin Luo, Xiang Xu
- Yi Yang, Xiao He, Rongseng Zhao, Wei Guo, Ming Zhu, Wei Xing, Dongpo Jiang, Chongyang Liu, Xiang Xu
- J Li, Q S Ran, B Hao, Xiang Xu, Hong-Feng Yuan
- Yi Yang, Xiao He, Mengwei Yao, Wei Xing, Luoquan Ao, Joseph A Bellanti, Song Guo Zheng, Xiang Xu
- Xiao He, Yi Yang, Mengwei Yao, Lei Yang, Luoquan Ao, Xueting Hu, Zhan Li, Xiaofeng Wu, Yan Tan, Wei Xing, Wei Guo, Joseph A Bellanti, Song Guo Zheng, Xiang Xu
- Xiao He, Yi Yang, Meng-Wei Yao, Ting-Ting Ren, Wei Guo, Ling Li, Xiang Xu
- Xiao He, Meng-Wei Yao, Ming Zhu, Dong-Lan Liang, Wei Guo, Yi Yang, Rong-Seng Zhao, Ting-Ting Ren, Xiang Ao, Wei Wang, Chun-Yu Zeng, Hua-Ping Liang, Dong-Po Jiang, Jian Yu, Xiang Xu
- Daqian Gu, Xiang Ao, Yu Yang, Zhuo Chen, Xiang Xu
- Yi Yang, Xiao He, Rongseng Zhao, Wei Guo, Ming Zhu, Wei Xing, Dongpo Jiang, Chongyang Liu, Xiang Xu